Multiple sclerosis (MS) is a neurological disorder that affects the central nervous system and can, to varying degrees, interfere with the transmission of nerve impulses throughout the brain, spinal cord and optic nerves. Since identification, MS has been the subject of intense, world-wide research, but its cause and cure remain elusive.
MS affects more than 25,000 Australians and 2.5 million people worldwide and is increasing by 4% every year. In Australia alone it costs more than $1 billion annually. Three out of every four people diagnosed are women and most people find out they have MS between the ages of 20-40.
MS is often a frustratingly unpredictable disease. Episodes can occur at varying time intervals affecting different areas of the central nervous system. There is no one symptom that indicates the presence of MS. No single test can establish an accurate diagnosis and there is currently no known cure for MS.
Menzies MS Flagship Program – ‘Towards Ending MS’
Menzies has proudly been at the forefront of research advancements in MS for twenty years. Our scientists, in collaboration with other researchers around the world, have been responsible for many of the major breakthroughs in MS research, including the link between UV exposure (Vitamin D) and a reduced risk of MS.
We also manage Australia’s largest cohort study of people with MS (the Australian MS Longitudinal Study). This research provides other researchers, advocacy groups and government agencies with practical information on how MS is impacting on people’s lives.
The Menzies MS Flagship Program has grown out of this intensive focus and research capability. It is a hub of interdisciplinary MS research, knowledge, knowledge translation and support within Menzies, which builds momentum across the wider MS community, nationally and internationally, towards improving outcomes for people living with MS and ultimately ending MS.
Through a shared passion between researchers, and partnerships with key organisations and groups, including those living with MS, their families and carers, the Flagship will provide the leadership and impetus for the establishment of the Australian MS Research & Translation Network.
For further information contact Vivienne Jones, Project Manager for the MS Flagship Program on Vivienne.email@example.com
MS Research Projects at Menzies
- Report: Health Economic Impact of Multiple Sclerosis in Australia in 2017 (Executive Summary) (PDF)
- Report: Health Economic Impact of Multiple Sclerosis in Australia in 2017 (Full Report) (PDF 2.6 MB)
- ANZGENE: The Genetics of Multiple Sclerosis
- Australian MS Longitudinal study (AMSLS)
- Gene Environment Interactions in Multiple Sclerosis
- Identifying a Genetic Basis of Multiple Sclerosis
- MS Longitudinal Study in Southern Tasmania
- PPMS Study
- The Auslong Study of Factors that Contribute to the Development & Progression of MS
- The Tasmanian MS Genes & Prevalence Study (MSPG)
- Vitamin D Gene Set Enrichment Analysis of MS Meta-analysis
- Gene by Environment Interactions in Multiple Sclerosis
- How do Multiple Sclerosis Risk Genes Work?
- Identifying Rare Genetic Variants Associated With the Onset of Multiple Sclerosis
- Multiple Sclerosis - Development of an Australian Gold Standard Health Economics Model in conjunction with MS Research Australia
- The Genetics of Brain Structure and Multiple Sclerosis
- Understanding oligodendrocyte turnover: the key to functional remyelination